Finance

Lists
Why is 000100 up 8,71%?
Dive Deeper
000100:KRX
Yuhan Corp
87 400,00 KRW
+8,71%
(+7 000,00) 1D
19 ოქტ, 15:30:01 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000100...
Open
80 500 KRW
High
87 800 KRW
Low
79 800 KRW
Mkt. cap
6,52 ტრლ.
Avg. vol.
207,75 ათ.
Volume
972,78 ათ.
Dividend
0,69%
Quarterly dividend
150 KRW
Ex-dividend date
26 თებ. 2026
P/E ratio
27,47
52-wk high
129 200 KRW
52-wk low
65 000 KRW
EPS
3 181 KRW
Shares outstanding
73,62 მლნ.
No. of employees
2 ათ.
Open
80 500 KRW
High
87 800 KRW
Low
79 800 KRW
Mkt. cap
6,52 ტრლ.
Avg. vol.
207,75 ათ.
Volume
972,78 ათ.
Dividend
0,69%
Quarterly dividend
150 KRW
Ex-dividend date
26 თებ. 2026
P/E ratio
27,47
52-wk high
129 200 KRW
52-wk low
65 000 KRW
EPS
3 181 KRW
Shares outstanding
73,62 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
9 საათის წინ
IBK cuts target for Yuhan stock to KRW 110,000
Profile
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
About Yuhan Corp
CEOვუკ ჯეი ჩო
Employees2,08 ათ.
Founded1926
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
570,01 მლრ.
546,07 მლრ.
526,78 მლრ.
639,45 მლრ.
Cost of goods sold
401,57 მლრ.
333,27 მლრ.
377,63 მლრ.
411,75 მლრ.
Cost of revenue
401,57 მლრ.
333,27 მლრ.
377,63 მლრ.
411,75 მლრ.
Research and development expenses
45,94 მლრდ.
78,04 მლრდ.
47,24 მლრდ.
60,12 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
94,69 მლრდ.
103,16 მლრ.
88,43 მლრდ.
99,40 მლრდ.
Operating expense
146,43 მლრ.
185,79 მლრ.
140,37 მლრ.
160,70 მლრ.
Total operating expenses
548,00 მლრ.
519,05 მლრ.
518,00 მლრ.
572,45 მლრ.
Operating income
22,01 მლრდ.
27,02 მლრდ.
8,78 მლრდ.
67,00 მლრდ.
Other non operating income
-2,09 მლრდ.
-4,58 მლრდ.
231,25 მლნ.
-6,59 მლრდ.
EBT including unusual items
35,18 მლრდ.
120,91 მლრ.
28,76 მლრდ.
88,37 მლრდ.
EBT excluding unusual items
34,24 მლრდ.
112,36 მლრ.
26,45 მლრდ.
84,89 მლრდ.
Income tax expense
14,01 მლრდ.
10,77 მლრდ.
5,39 მლრდ.
20,33 მლრდ.
Effective tax rate
39,83%
8,91%
18,75%
23,00%
Other operating expenses
1,68 მლრდ.
3,00 მლრდ.
1,94 მლრდ.
2,87 მლრდ.
Net income
25,28 მლრდ.
114,43 მლრ.
27,04 მლრდ.
70,32 მლრდ.
Net profit margin
4,44%
20,96%
5,13%
11,00%
Earnings per share
348,00
1,53 ათ.
372,00
950,00
Interest and investment income
2,11 მლრდ.
2,13 მლრდ.
2,35 მლრდ.
2,47 მლრდ.
Interest expense
-3,99 მლრდ.
-3,91 მლრდ.
-3,86 მლრდ.
-3,89 მლრდ.
Net interest expenses
-1,88 მლრდ.
-1,77 მლრდ.
-1,51 მლრდ.
-1,42 მლრდ.
Depreciation and amortization charges
2,12 მლრდ.
962,24 მლნ.
1,52 მლრდ.
1,48 მლრდ.
EBITDA
40,00 მლრდ.
44,17 მლრდ.
27,88 მლრდ.
90,47 მლრდ.
Gain or loss from assets sale
9,44 მლნ.
-9,65 მლრდ.
15,64 მლნ.
291,06 მლნ.
AI content may include mistakes. Learn more
Google აპები